Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib

Glioblastoma is an aggressive form of central nervous system tumor. Recurrence rates following primary therapy are high, and few second-line treatment options provide durable clinical benefit. Aberrations of the epidermal growth factor receptor (EGFR) gene are observed in up to 57% of glioblastoma c...

Descripción completa

Detalles Bibliográficos
Autores principales: Owen, Scott, Alken, Scheryll, Alshami, Jad, Guiot, Marie-Christine, Kavan, Petr, Reardon, David A, Muanza, Thierry, Gibson, Neil, Pemberton, Karine, Solca, Flavio, Cseh, Agnieszka, Saran, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005142/
https://www.ncbi.nlm.nih.gov/pubmed/35422631
http://dx.doi.org/10.2147/OTT.S346725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005142/
https://www.ncbi.nlm.nih.gov/pubmed/35422631
http://dx.doi.org/10.2147/OTT.S346725

Ejemplares similares